Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer's Disease - Test2 - elhamkhani - TriplyDB

Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer's Disease

Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer's Disease

http://www.wikidata.org/entity/Q26739412

about

Drug candidates in clinical trials for Alzheimer's disease.Tau PET imaging: present and future directions.Maysin and Its Flavonoid Derivative from Centipedegrass Attenuates Amyloid Plaques by Inducting Humoral Immune Response with Th2 Skewed Cytokine Response in the Tg (APPswe, PS1dE9) Alzheimer's Mouse Model.Salidroside reduces tau hyperphosphorylation via up-regulating GSK-3β phosphorylation in a tau transgenic Drosophila model of Alzheimer's disease.Functional analyses of major cancer-related signaling pathways in Alzheimer's disease etiology.Beyond immunotherapy: new approaches for disease modifying treatments for early Alzheimer's disease.Drugs in Clinical Trials for Alzheimer's Disease: The Major Trends.New routes in frontotemporal dementia drug discovery.Alzheimer's disease and metabolic syndrome: A link from oxidative stress and inflammation to neurodegeneration.Tracking progressive pathological and functional decline in the rTg4510 mouse model of tauopathy.Methylene Blue Exerts Anticonvulsant and Neuroprotective Effects on Self-Sustaining Status Epilepticus (SSSE) Induced by Prolonged Basolateral Amygdala Stimulation in Wistar Rats.Role of Tau Acetylation in Alzheimer's Disease and Chronic Traumatic Encephalopathy: The Way Forward for Successful Treatment.Optical coherence tomography identifies outer retina thinning in frontotemporal degeneration.Understanding mechanisms and seeking cures for Alzheimer's disease: why we must be "extraordinarily diverse".Corticobasal degeneration: key emerging issues.Elevated phospholipase D isoform 1 in Alzheimer's disease patients' hippocampus: Relevance to synaptic dysfunction and memory deficits.Neuroimmune Tau Mechanisms: Their Role in the Progression of Neuronal Degeneration.Exosomes: a novel therapeutic target for Alzheimer's disease?Cognitive composite score association with Alzheimer's disease plaque and tangle pathology

P2860

Q33916749-734F4263-CD27-4E1F-ABF5-039489329217 Q34680852-CCB6F40F-CDC5-4890-B89A-3AC1975B588A Q36245427-63487D45-E8CF-4709-B5D4-7D890D9A219D Q37449999-7719AC04-2985-487F-9480-111E145E117D Q38659874-227BF526-897D-4E80-8C96-1E85DBE9A5AD Q38797428-58C1B249-694D-4C7B-B1B7-2A1CBF9DE5A9 Q39022532-D4A65B34-2D62-4789-A068-025DB58D7E5B Q39344391-28947CD8-9408-4D9F-85F4-440BF4B85544 Q39398227-38136787-C2F1-4635-B188-BF671E773319 Q41695282-2A9327B4-5D63-47B7-B56D-E3D146EFB780 Q47226005-6D54BAB1-84F1-4D62-89DA-04932620B047 Q47256420-3C739D9D-A21E-4023-819B-4F64CDFB3C9C Q47626175-D39D81ED-BB49-44B2-B15D-4C5A01E0C0DE Q48762558-9A885003-527C-4EE8-A8F9-020EE0EA7B25 Q50074075-0816B109-C7F3-4752-BF93-B98210AE35A6 Q51761051-8375A360-EA77-4DE0-92B5-62A3A6832C94 Q52344625-500C75ED-7675-47F5-9316-D4B9EED8C0D6 Q55416682-53EE94EC-B44B-4FA4-8D94-5AADB16FB679 Q58751300-9809F983-F263-4287-B83E-7B971448960B

P2860

Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer's Disease

http://www.wikidata.org/entity/Q26739412

description

2016 nî lūn-bûn

@nan

2016 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

name

Tau-Centric Targets and Drugs ...... eatment of Alzheimer's Disease

@ast

Tau-Centric Targets and Drugs ...... eatment of Alzheimer's Disease

@en

Tau-Centric Targets and Drugs ...... eatment of Alzheimer's Disease

@nl

type

label

Tau-Centric Targets and Drugs ...... eatment of Alzheimer's Disease

@ast

Tau-Centric Targets and Drugs ...... eatment of Alzheimer's Disease

@en

Tau-Centric Targets and Drugs ...... eatment of Alzheimer's Disease

@nl

prefLabel

Tau-Centric Targets and Drugs ...... eatment of Alzheimer's Disease

@ast

Tau-Centric Targets and Drugs ...... eatment of Alzheimer's Disease

@en

Tau-Centric Targets and Drugs ...... eatment of Alzheimer's Disease

@nl

P1433

Q26739412-2C6004D0-643B-444A-B157-066019AB3428

P1476

Q26739412-BB9F3D91-0283-45DB-81EC-297653B3FC70

P2093

Q26739412-06879EB3-471A-4A58-BA4C-802297426393

Q26739412-1EF89A4E-477C-479F-8C87-E18A197674F1

Q26739412-93876339-00E4-48BF-8B95-8BB76CF98761

Q26739412-BD3B3258-DDB2-4469-AFFD-D461013D35D8

Q26739412-C031DBC7-9269-4DA1-8430-71F17920E560

Q26739412-D0957ED8-D827-48F5-A7A5-B4AEC131512D

Q26739412-D59C9383-884E-4BA5-BE48-818A9A990BBD

Q26739412-DD88EEE8-4339-4FB0-9D5D-EFB6C3490A0D

P275

Q26739412-7E7B75E5-4E04-459A-AE19-5A961F2E9580

P2860

Q26739412-00806ACB-06FA-4691-920B-7795DD7B0050

Q26739412-03363DE1-36A5-49C6-A0BE-3294ABFFB566

Q26739412-03E117E1-E66D-4293-9154-78AB7C1FCA6F

Q26739412-05585783-44FC-45C9-9BB5-C60685421855

Q26739412-0570DDDE-9943-4929-95D4-2EF9DD19900C

Q26739412-05EE0A13-061D-423E-A08D-D2C9174A3FCA

Q26739412-0A097D39-50ED-4376-AE59-48B016B33886

Q26739412-0A9964AD-30FF-44EE-BA51-D70BA3AAC398

Q26739412-0D8987CF-1CCD-4C32-B843-6FEC3D904EF2

Q26739412-0DCBA6D3-736C-454B-9C6B-55F099AD4474

P304

Q26739412-2317F103-585F-4B3B-8DD2-239420F67928

P31

Q26739412-4519501C-E61E-4FF8-B1C8-24EF33887325

Q26739412-4E142E6A-5817-4D75-A4E8-F02593E3CB84

P3181

Q26739412-BC9C60D3-168A-481D-91B8-D7064E6446F7

P356

Q26739412-6D38D81F-4321-421D-9440-CA41BAB8306B

P407

Q26739412-B25E7643-AC97-4B7F-BBF0-87AE4E9CCAE6

P478

Q26739412-1F844D99-C9B8-43D6-B652-24A4F25E9473

P50

Q26739412-00AE4506-369F-45DE-921D-16FDC100D074

Q26739412-0C3781A1-D8DD-4FBF-A28F-476BC0366FCC

Q26739412-76B8DE04-3F15-4E9A-96E3-04210284DB44

Q26739412-7E21EFE2-82CF-4743-AA90-0650990C612C

Q26739412-D2AD986B-2FB7-42EC-83B5-7C806927D2A6

P5008

Q26739412-DC8B31A5-1E13-4FAE-B01D-DD934888CE73

P577

Q26739412-D3CF8D43-43CC-477D-83E7-46092E365DA2

P698

Q26739412-72C9902E-C4CC-4254-99F4-BDD66EDEBE65

P921

Q26739412-0725A7F6-1701-4D1B-9013-89096CCAA786

Q26739412-6FE8D762-347A-4D2B-B75E-8EA5D847953D

Q26739412-780CEBDF-44ED-4FD2-B618-49BEBE30E3DB

Q26739412-C83EA37A-BD9E-4912-A0E4-6C4B56C5D67D

Q26739412-DFA4D2B5-831D-46DE-A59B-55F840C4FE90

P932

Q26739412-B0B25ACC-F4D1-4F99-9BFF-FE2E1761CC11

P3181

P356

P1433

BioMed Research International

P1476

Tau-Centric Targets and Drugs ...... eatment of Alzheimer's Disease

@en

P2093

Alberto Pilotto

http://www.w3.org/2001/XMLSchema#string

Andrea Santamato

http://www.w3.org/2001/XMLSchema#string

Antonello Bellomo

http://www.w3.org/2001/XMLSchema#string

Antonio Daniele

http://www.w3.org/2001/XMLSchema#string

Antonio Greco

http://www.w3.org/2001/XMLSchema#string

Chiara Zecca

http://www.w3.org/2001/XMLSchema#string

Maria Rosaria Barulli

http://www.w3.org/2001/XMLSchema#string

Vincenzo Solfrizzi

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Strong gametocytocidal effect of methylene blue-based combination therapy against falciparum malaria: a randomised controlled trial

Complex Disposition of Methylthioninium Redox Forms Determines Efficacy in Tau Aggregation Inhibitor Therapy for Alzheimer's Disease

Tau-aggregation inhibitor therapy for Alzheimer's disease

Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines

Phosphoprotein phosphatase 2A: a novel druggable target for Alzheimer's disease

Methylene blue reduces aβ levels and rescues early cognitive deficit by increasing proteasome activity

Transmission and spreading of tauopathy in transgenic mouse brain

Hyperphosphorylation of microtubule-associated protein tau: a promising therapeutic target for Alzheimer disease

Methylene blue and serotonin toxicity: inhibition of monoamine oxidase A (MAO A) confirms a theoretical prediction

Protein Folding and Mechanisms of Proteostasis

P304

3245935

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

487367

http://www.w3.org/2001/XMLSchema#string

P356

10.1155/2016/3245935

http://www.w3.org/2001/XMLSchema#string

P407

P478

2016

http://www.w3.org/2001/XMLSchema#string

P50

Francesco Panza

Giancarlo Logroscino

P5008

P577

2016-06-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27429978

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

heterocyclic compound

cytoskeletal proteins

nerve tissue proteins

P932

4939203

http://www.w3.org/2001/XMLSchema#string